TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting [Yahoo! Finance]
TG Therapeutics, Inc. (TGTX)
Last tg therapeutics, inc. earnings: 11/12 07:34 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.tgtherapeutics.com
Company Research
Source: Yahoo! Finance
post-marketing studies being undertaken for BRIUMVI ® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 Consortium of Multiple Sclerosis Centers (CMSC) annual meeting. Presentations are now public and can be viewed using the below links. Link to Poster Presentation: A Post-Marketing Study Evaluating the Presence and Concentration of BRIUMVI in Breast Milk (PROVIDE) Lead Author: Riley Bove, MD - UCSF Weill Institute of Neurosciences, Dept. of Neurology Univ. of California San Francisco, San Francisco, CA Link to Poster Presentation: BRIUMVI Pregnancy Registry: A Prospective Study of Pregnancy and Infant Outcomes in Patients Treated with BRIUMVI Lead Author: Riley Bove, MD - UCSF Weill Institute of Neurosciences, Dept. of Neurology Univ. of California San Francisco, San Francisco, CA Presentations are available on the Publications page, located within the Pipeline section, of the Company's website at https://www.tgtherapeutics.com/pub
Show less
Read more
Impact Snapshot
Event Time:
TGTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TGTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TGTX alerts
High impacting TG Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
TGTX
News
- Top High Growth Tech Stocks For September 2024 [Yahoo! Finance]Yahoo! Finance
- TG Therapeutics: A Look At New Briumvi Data And Ocrevus Zunovo Approval [Seeking Alpha]Seeking Alpha
- High Growth Tech Stocks To Watch In September 2024 [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch In September 2024 [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch In September 2024 [Yahoo! Finance]Yahoo! Finance
TGTX
Earnings
- 8/6/24 - Beat
TGTX
Sec Filings
- 8/9/24 - Form 10-Q
- 8/9/24 - Form 10-K/A
- 8/6/24 - Form 8-K
- TGTX's page on the SEC website